Hypogonadotropic hypogonadism due to novel FGFR1 mutations

9Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Objective: The underlying genetic etiology of hypogonadotropic hypogonadism (HH) is heterogeneous. Fibroblast growth factor signaling is pivotal in the ontogeny of gonadotropin-releasing hormone neurons. Loss-of-function mutations in FGFR1 gene cause variable HH phenotypes encompassing pubertal delay to idiopathic HH (IHH) or Kallmann syndrome (KS). As FGFR1 mutations are common, recognizing mutations and associated phenotypes may enhance clinical management. Methods: Using a candidate gene approach, we screened 52 IHH/KS patients. Results: We identified three novel (IVS3-1G>C and p.W2X, p.R209C) FGFR1 gene mutations. Despite predictive null protein function, patients from the novel mutation families had normosmic IHH without non-reproductive phenotype. Conclusion: These findings further emphasize the great variability of FGFR1 mutation phenotypes in IHH/KS.

Cite

CITATION STYLE

APA

Akkuş, G., Kotan, L. D., Durmaz, E., Mengen, E., Turan, İ., Ulubay, A., … Topaloğlu, A. K. (2017). Hypogonadotropic hypogonadism due to novel FGFR1 mutations. JCRPE Journal of Clinical Research in Pediatric Endocrinology, 9(2), 95–100. https://doi.org/10.4274/jcrpe.3908

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free